Komplikatives Hämatomediastinum einer 76-jährigen Patientin nach Durchführung einer endosonografisch gesteuerten transbronchialen Kryobiopsie (EBUS-TBKB) bei Verdacht einer Lymphomerkrankung

Zusammenfassung

Wir präsentieren den Fall einer Patientin mit schwerem Verlauf einer komplikativen mediastinalen Blutung nach endosonografisch gesteuerter transbronchialer Kryobiopsie (EBUS-TBKB) bei Verdacht einer fortgeschrittenen Lymphomerkrankung. Die EBUS-TBKB ist eine noch nicht routinemäßig angewandte effektive Untersuchungsmethode in der interventionellen Pneumologie zur Diagnose von Erkrankungen mit mediastinalen Lymphknotenvergrößerungen und intrathorakalen Tumoren, mit der große Gewebezylinder im Mediastinum gewonnen werden können. Aufgrund der hohen diagnostischen Wertigkeit der endobronchialen ultraschallgesteuerten transbronchialen Nadelaspiration (EBUS-TBNA) zur Abklärung einer Lymphadenopathie sollte die Untersuchung nicht als Routineanwendung erfolgen. Indikationen für eine primäre EBUS-TBKB können sich bei Verdacht auf intrathorakale maligne Lymphome oder andere seltene Tumoren, bei denen umfangreiches unfragmentiertes Gewebematerial für die Diagnosefindung erforderlich ist, ergeben. Eine seltene und bisher nicht in der Literatur beschriebene Komplikation ist ein Hämatomediastinum, sodass vor Intervention eine sorgfältige Risikoabwägung von möglicherweise auftretenden Blutungskomplikationen erfolgen sollte und die invasivere Mediastinoskopie eine sicherere Untersuchungsmethode sein kann.

Abstract

We present the case of a patient with severe complications from mediastinal bleeding after endosonographically guided transbronchial cryobiopsy (EBUS-TBKB) with suspected advanced lymphoma. The EBUS-TBKB is a new effective examination method in interventional pneumology for the diagnosis of diseases with mediastinal lymph node enlargement and intrathoracic tumors, with which large tissue cylinders in the mediastinum can be obtained. Due to the high diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the clarification of lymphadenopathy, the examination should not be carried out as a routine application. Indications for a primary EBUS-TBKB arise when there is a suspicion of intrathoracic malignant lymphomas or other rare tumors in which extensive unfragmented tissue material is required for diagnosis. A rare complication that has not yet been described in the literature is a hematomediastinum, so that a careful risk assessment of possible bleeding complications should be carried out before intervention and the more invasive mediastinoscopy can be a safer examination method.

Schlüsselwörter

Hämatomediastinum - Mediastinale Lymphadenopathie - Kryobiopsie

Keywords

Hämatomediastinum - mediastinal lymphnode enlargement - cryobiopsie

Publication History

Received: 27 October 2022

Accepted after revision: 19 December 2022

Article published online:
02 February 2023

• Literatur

• 1 Wong M, Yasufuk K, Nakajima T. et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J 2007; 29: 1182-1186
• 2 Stoy SP, Segal JP, Mueller J. et al. Feasibility of endobronchial ultrasound-guided transbronchial needle aspiration cytology specimens for next generation sequencing in non-small-cell lung cancer. Clin Lung Cancer 2018; 19: 230-238
• 3 Shitrit D, Adir Y, Avriel A. et al. EBUS-TBNA is Sufficient for Successful Diagnosis of Silicosis with Mediastinal Lymphadenopathy. Lung 2018; 196: 441-445
• 4 NICE Guideline Updates Team (UK). Evidence reviews for effectiveness of non-ultrasound-guided TBNA, EBUS-TBNA or EUS-FNA for people with a probability of mediastinal malignancy: Lung cancer: diagnosis and management: Evidence review. London: National Institute for Health and Care Excellence (UK); 2019
• 5 Trisolini R, Baughman RP, Spagnolo P. et al. Endobronchial ultrasound-guided transbronchial needle aspiration in sarcoidosis: Beyond the diagnostic yield. Respirology 2019; 24: 531-542
• 6 Tone M, Inomata M, Awano N. et al. Comparison of adequacy between transbronchial lung cryobiopsy samples and endobronchial ultrasound-guided transbronchial needle aspiration samples for next-generation sequencing analysis. Thorac 2021; 12: 251-258
• 7 Murthi M, Donna E, Arias S. et al. Diagnostic Accuracy of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) in Real Life. Front Med (Lausanne) 2020; 7: 118 eCollection 2020
• 8 Gupta N, Muthu V, Agarwal R. et al. Role of EBUS-TBNA in the Diagnosis of Tuberculosis and Sarcoidosis. J Cytol 2019; 36: 128-130
• 9 Udagawa H, Kirita K, Naito T. et al. Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm study. Cancer Sci 2020; 111: 2488-2498
• 10 Maemondo M, Inoue A, Kobayashi K. et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010; 362: 2380-2388
• 11 Zhou C, Wu YL, Chen G. et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, openlabel, randomised, phase 3 study. Lancet Oncol 2011; 12: 735-742
• 12 Wu YL, Zhou C, Hu CP. et al. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): An open-label, randomised phase 3 trial. Lancet Oncol 2014; 15: 213-222
• 13 Soria JC, Ohe Y, Vansteenkiste J. et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 2018; 378: 113-125
• 14 Kage H, Kohsaka S, Shinozaki-Ushiku A. et al. Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing. Cancer Sci 2019; 110: 2652-2657
• 15 Schubert J, Ecke M. Pneumologische Zytopathologie. Berlin: Walter de Gruyter GmbH; 2019
• 16 Zhang J, Guo J-R, Huang Z-S. et al. Transbronchial mediastinal cryo-biopsy in the diagnosis of mediastinal lesions: a randomised trial. Eur Respir J 2021; 58: 2100055
• 17 The American Thoracic Society and The European Respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997; 156: 320-332
• 18 Detterbeck FC, Jantz MA, Wallace M. et al. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132 (Suppl. 03) 202S-220S
• 19 Daly ME, Singh N, Ismaila N. et al. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline. J Clin Oncol 2021; 22: 1-31
• 20 Dhooria S, Mehta RM, Madan K. et al. A Multicenter Study on the Utility of EBUS-TBNA and EUS-B-FNA in the Diagnosis of Mediastinal Lymphoma. Bronchology Interv Pulmonol 2019; 26: 199-209
• 21 Lerut T, De Leyn P. Mediastinoscopy. Shields General Thoracic Surgery 2019; 1: 297-307
• 22 Franke K-J, Linzenbold W, Nuessle D. et al. A New Tool for Transbronchial Cryobiopsies in the Lung: An Experimental Feasibility ex vivo Study. Respiration 2016; 91: 228-234
• 23 Darwiche K, Theegarten D, Wohlschläger J. et al. Gewinnung einer EBUS-geführten PE mittels einer neu entwickelten Zange. Pneumologie 2011; 65 – V65
• 24 Bramley K, Pisani MA, Murphy TE. et al. EBUS-Guided Cautery-Assisted Transbronchial Forceps Biopsies: Safety and Sensitivity Relative to Transbronchial Needle Aspiration. Ann Thorac Surg 2016; 101: 1870-1876
• 25 Gonuguntla HK, Shah M, Gupta N. et al. Endobronchial ultrasound-guided transbronchial cryo-nodalbiopsy: a novel approach for mediastinal lymph nodesampling. Respirol Case Rep 2021; 9: e00808
• 26 Elmufdi FS, Peterson MK, Niccum D. et al. Evaluating Yield of 19 Versus 21 G EBUS-TBNA Needles: A Prospective Study. J Bronchology Interv Pulmonol 2021; 28: 29-33